Research ArticleCARDIOVASCULAR
Reversibility versus Persistence of GPIIb/IIIa Blocker-Induced Conformational Change of GPIIb/IIIa (αIIbβ3, CD41/CD61)
Meike Schwarz, Yasuhiro Katagiri, Masaharu Kotani, Nicole Bassler, Christoph Loeffler, Christoph Bode and Karlheinz Peter
Journal of Pharmacology and Experimental Therapeutics March 2004, 308 (3) 1002-1011; DOI: https://doi.org/10.1124/jpet.103.058883